Effective Management of Acute and Chronic Pain with Opioid Analgesics, 2nd Edition _ ________________
R156-37-104. Organization - Relationship to Rule R156-1. The organization of this rule and its relationship to Rule R156-1 is as described in Section R156-1-107. R156-37-301. License Classifications - Restrictions. 1. Under Subsection 58-37-6(2), the Division may issue a controlled substance license to: a. a qualified person licensed in good standing in the classification of:
R156-37-302. Qualifications for Licensure - Application Requirements. 1. An applicant for a controlled substance license shall: a. submit an application in a form prescribed by the Division; b. pay the fee established by the Division under Section 63J-1-504; and c. be currently licensed in good standing by the state in a classification in Section R156-37- 301. 3. The Division and the reviewing board may request from the applicant information that is reasonable and necessary to permit an evaluation of: a. the applicant’s qualifications to engage in practice with controlled substances; and b. the public interest in the issuance of a controlled substance license to the applicant. 4. To determine if an applicant is qualified for licensure, the Division may: a. assign the application to a qualified and appropriate licensing board for review and recommendation to the Division; and b. conduct site inspections, review research
i. pharmacist; ii. optometrist; iii. podiatric physician; iv. dentist; v. osteopathic physician and surgeon; vi. physician and surgeon; vii. physician assistant; viii. veterinarian; ix. advanced practice registered nurse or advanced practice registered nurse- certified registered nurse anesthetist; x. certified nurse midwife; xi. naturopathic physician; xii. anesthesiologist assistant; xiii. Class A pharmacy under Subsection R156-17b-302(1); xiv. Class B pharmacy under Subsection R156-17b-302(2); xv. Class C pharmacy under Subsection R156-17b-302(3); xvi. Class D pharmacy under Subsection R156-17b-302(4); or xvii. Class E pharmacy under Subsection R156-17b-302(5); or xviii. the Utah Department of
protocol, conduct interviews with persons knowledgeable about the applicant, and conduct any other investigation that is
reasonable and necessary to determine the applicant is qualified to receive a controlled substance license. R156-37-305. Qualifications for Licensure -- Drug Enforcement Administration (DEA) Registration - Active License. 1a. Except as specified in Subsection (1)(b), an individual who obtains a controlled substance license shall obtain a DEA registration within 120 days of the date the controlled substance license is issued. b. A controlled substance licensee who has written consent from the licensee’s employer to use the employer’s hospital or institution DEA registration to administer or prescribe controlled substances, or both, is not required to obtain an individual practitioner DEA registration. 2. A person who holds a controlled substance license shall maintain their license under Subsection R156-37-301(1) active and in good standing. 3. If a person’s license under Subsection R156-37-301(1) expires or is revoked, surrendered, or suspended, the Division shall:
Corrections, for the conduct of execution by the administration of lethal injection in accordance with Section 77-18-113.
2. The Division may restrict a controlled substance license to the extent the Division, in collaboration with the appropriate licensing boards, determines necessary to protect the health, safety, or welfare of:
a. the public; or b. the licensee.
3. A person holding a restricted controlled substance license may use the license only to the extent of the restricted terms and conditions.
30
MDUT1125
Powered by FlippingBook